NASDAQ:ADMP Adamis Pharmaceuticals (ADMP) Stock Price, News & Analysis Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range N/A50-Day Range$0.77▼$3.9952-Week Range N/AVolume119,800 shsAverage Volume811,695 shsMarket Capitalization$7.26 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Adamis Pharmaceuticals alerts: Email Address Ad DarwinTop Stock Unveiled!Ready to discover the standout stock of 2024? We’ve identified a single buy & hold gem that’s poised to redefine your portfolio. Download our exclusive report now and dive into the Insights. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time.Get Your Free Report About Adamis Pharmaceuticals Stock (NASDAQ:ADMP)Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease. Its products include SYMJEPI epinephrine injection for the emergency treatment of allergic reactions to stinging and biting insects, allergen immunotherapy, foods, drugs, diagnostic testing substances, and other allergens, as well as idiopathic or exercise-induced anaphylaxis; and ZIMHI naloxone injection for the treatment of opioid overdose. The company is headquartered in San Diego, California.Read More Ad WealthPressNew trading system called MSFT, NVDA & MSFTLook 2023 kind of sucked from a trading standpoint… Despite the market finishing 24% higher…. Just seven stocks did all of the work… Unless you were holding or actively trading those 7 stocks, your trading year probably wasn’t as fruitful as you had hoped… According to my research, my new trading system would have spotted all seven of the “Magnificent stocks” MONTHS before they reached the highs they are trading at today.Just follow this link here! ADMP Stock News HeadlinesNovember 8, 2023 | morningstar.comDMK Pharmaceuticals Corp DMKSeptember 7, 2023 | msn.comAdamis changes name to DMK Pharmaceuticals, ticker to DMKJuly 26, 2024 | Awesomely, LLC (Ad)Automatic Income (from home)Everyone’s talking about this new income hack that could generate triple digit returns on your money. But here’s the best part…September 7, 2023 | finance.yahoo.comAdamis Pharmaceuticals Changes Name to DMK Pharmaceuticals to Reflect New Strategic FocusAugust 21, 2023 | finanznachrichten.deAdamis Pharmaceuticals Corporation: Adamis Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate UpdateAugust 21, 2023 | finance.yahoo.comAdamis Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate UpdateAugust 4, 2023 | finance.yahoo.comAdamis Pharmaceuticals Announces Closing of $8.0 Million Public OfferingAugust 2, 2023 | finance.yahoo.comAdamis Pharmaceuticals Announces Pricing of $8.0 Million Public OfferingJuly 26, 2024 | Awesomely, LLC (Ad)Automatic Income (from home)Everyone’s talking about this new income hack that could generate triple digit returns on your money. But here’s the best part…August 1, 2023 | msn.comAdamis Pharmaceuticals Stock Soars To More Than Double - What's Going On?August 1, 2023 | msn.comAdamis stock soars as high as 480% amid asset sale, drug study newsJuly 28, 2023 | marketwatch.comAdamis Pharma to Fund Clinical Study with University of Leiden Opioid ExpertJuly 28, 2023 | finance.yahoo.comAdamis Pharmaceuticals to Fund ZIMHI® Clinical Study with University of Leiden Opioid ExpertJune 26, 2023 | benzinga.comAdamis Pharmaceuticals Announces NIH Grant Funding For Treatment Of Alcohol Use Disorder, Size Not DisclosedJune 26, 2023 | finance.yahoo.comAdamis Pharmaceuticals Announces NIH Grant Funding for the Treatment of Alcohol Use DisorderJune 22, 2023 | finance.yahoo.comAdamis Pharmaceuticals Participated in White House Meeting Regarding Opioid Overdose PreventionJune 4, 2023 | fool.comAdamis Pharmaceuticals (NASDAQ: ADMP)May 31, 2023 | benzinga.comAdamis Pharmaceuticals CEO Awarded $210K Worth of Stock OptionsSee More Headlines Receive ADMP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Adamis Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/31/2022Today7/26/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolNASDAQ:ADMP CUSIPN/A CIK887247 Webwww.adamispharmaceuticals.com Phone(858) 997-2400FaxN/AEmployees11Year Founded2006Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-26,480,000.00 Net Margins-502.73% Pretax Margin-471.80% Return on Equity-420.53% Return on Assets-256.87% Debt Debt-to-Equity RatioN/A Current Ratio0.23 Quick Ratio0.19 Sales & Book Value Annual Sales$4.76 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value($1.26) per share Price / BookN/AMiscellaneous Outstanding Shares9,360,000Free Float9,237,000Market Cap$7.26 million OptionableOptionable Beta1.27 Social Links 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMr. David J. Marguglio (Age 53)Co-Founder, Interim CFO. Pres & COO Comp: $526.35kDr. Ebrahim Versi M.D. (Age 70)Ph.D., CEO & Chair of the Board Ms. Jennifer C. SuskiSr. Director of MarketingMr. Eddie Wabern Glover (Age 73)Chief Exec. Officer of US Compounding Inc Mr. Robert B. Rothermel (Age 79)Consultant Key CompetitorsAlvotechNASDAQ:ALVOWBiofronteraNASDAQ:BFRIWClever LeavesNASDAQ:CLVRWCyclo TherapeuticsNASDAQ:CYTHWProcaps GroupNASDAQ:PROCWView All Competitors ADMP Stock Analysis - Frequently Asked Questions How were Adamis Pharmaceuticals' earnings last quarter? Adamis Pharmaceuticals Co. (NASDAQ:ADMP) announced its quarterly earnings data on Thursday, March, 31st. The specialty pharmaceutical company reported ($4.20) EPS for the quarter, missing the consensus estimate of ($2.80) by $1.40. Adamis Pharmaceuticals had a negative net margin of 502.73% and a negative trailing twelve-month return on equity of 420.53%. When did Adamis Pharmaceuticals' stock split? Adamis Pharmaceuticals's stock reverse split on the morning of Monday, May 22nd 2023. The 1-70 reverse split was announced on Monday, May 22nd 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, May 22nd 2023. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split. What other stocks do shareholders of Adamis Pharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some other companies that Adamis Pharmaceuticals investors own include Trevena (TRVN), Amarin (AMRN), Sorrento Therapeutics (SRNE), Verastem (VSTM), Dynavax Technologies (DVAX), Novavax (NVAX) and SCYNEXIS (SCYX). This page (NASDAQ:ADMP) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredNEW AI developed by trader who won 1,129% (in 2 days)Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands o...Monument Traders Alliance | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adamis Pharmaceuticals Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Adamis Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.